Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 76

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 19
Chunk 76
---
 various jurisdictions in which the Company operates

are
subject to change. The determination of income tax expense and deferred tax involves judgment and estimates as to the future taxable
earnings, expected timing of reversals of deferred tax assets and liabilities, and interpretations of laws in the countries in which
the Company operates. The Company is subject to assessments by tax authorities who may interpret the tax law differently. Changes in
these estimates may materially affect the final amount of deferred taxes or the timing of tax payments. If a positive forecast of taxable
income indicates the probable use of a deferred tax asset, especially when it can be utilized without a time limit, that deferred tax
asset is usually recognized in full.

Going
concern

Management
has applied judgements in the assessment of the Company’s ability to continue as a going concern when preparing its financial statements
for the year ended December 31, 2024. In assessing whether the going concern assumption is appropriate, management takes into account
all available information about the future, which is at least, but is not limited to, twelve months from the end of the reporting period.
The factors considered by management are disclosed in Note 1.

  Application                                                                                    
  of new and revised accounting standards and accounting standards issued but not yet effective  
 ─────────────────────────────────────────────────────────────────────────────────────────────────

There
are no significant changes in accounting policies but several amendments to IFRS Accounting Standards and interpretations became effective
for annual periods beginning on or after January 1, 2024.

The
Company has adopted the amendments to IAS 1 Presentation of Financial Statements as well as IAS 8 Changes in Accounting Estimates and
Errors regarding the disclosure of accounting policies and accounting estimates, IFRS 16 Leases, Statement of Cash Flows Financial Instruments: Disclosures - Supplier Finance Arrangements

4. ACCOUNTS RECEIVABLE

The
Company’s accounts receivable consists of the following:

SCHEDULE OF ACCOUNTS RECEIVABLE

                         December                   December               
                         31, 2024                   31, 2023               
 ───────────────────────────────────────────────────────────────────────────
                         $                          $                      
  Trade                                414,263                    420,998  
  GST                                    5,324                      6,691  
  Total                                419,587                    427,689  

5. PREPAID EXPENSES AND DEPOSITS

The
balance consists of prepaid expenses to vendors of $ 7,408 16